TESARO Announces Participation in Three Investor Conferences
October 24 2016 - 4:05PM
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical
company, today announced its participation in three upcoming
investor conferences. The three conferences are:
- The Credit Suisse 25th Annual Healthcare Conference at
The Phoenician in Scottsdale, Arizona on Monday, November 7 and
Tuesday, November 8. Lonnie Moulder, CEO of TESARO, and
Mary Lynne Hedley, Ph.D., President and COO of TESARO, will present
on November 8 at 8:30 AM MT and will also host meetings with
investors.
- The Global Mizuho Investor Conference at The Omni
Berkshire Place in New York, New York on Monday, November
14. Tim Pearson, EVP and CFO of TESARO, will participate
in meetings with investors.
- The Raymond James Boston Fall Investors Conference at
The State Room in Boston, Massachusetts on Tuesday, November
15. Tim Pearson, EVP and CFO of TESARO, will participate
in meetings with investors.
A live webcast of the presentation at the Credit Suisse
conference will be available by visiting the Investors section of
the TESARO website at www.tesarobio.com. An archived replay of this
webcast will be available on the Company’s website for 14 days
following the conference.
About TESAROTESARO is an oncology-focused
biopharmaceutical company devoted to providing transformative
therapies to people bravely facing cancer. For more information,
visit www.tesarobio.com, and follow us on Twitter and LinkedIn.
For additional information, please contact:
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Apr 2023 to Apr 2024